Skip to main content

Advertisement

Log in

Experimental validation of talc pleurodesis for carcinomatous pleuritis in an animal model

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objective

This study was performed to evaluate the change of pleural cavity by talc pleurodesis for carcinomatous pleuritis in an animal model.

Methods

Models of malignant pleuritis were produced by an intra-venous injection of lung adenocarcinoma cells to male BALB/c nude mice at 6 weeks of age. Two weeks after the injection, either talc or saline was injected into the left thoracic cavity and the mice were further observed for 4 weeks. Six weeks after the injection, they were killed and the occurrence of lung cancer, amount of pleural effusion, and histological change of the pleural cavity were examined and compared between the two groups with or without talc administration.

Results

Talc administration caused a significant reduction in pleural effusion with no increase of pleural adhesion. Talc administration resulted in marked pleural thickening compared to saline treatment. The vascular architecture and its area did not differ between the two groups.

Conclusion

Talc pleurodesis to reduce pleural effusion is valid for carcinomatous pleuritis, potentially through an acceleration of pleural thickening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Weissberg D, Ben-Zeev I. Talc pleurodesis. Experience with 360 patients. J Thorac Cardiovasc Surg. 1993;106:689–95.

    CAS  PubMed  Google Scholar 

  2. Almind M, Lange P, Viskum K. Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis. Thorax. 1989;44:627–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Light RW, O’Hara VS, Moritz TE, McElhinney AJ, Butz R, Haakenson CM, et al. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. JAMA. 1990;264:2224–30.

    Article  CAS  PubMed  Google Scholar 

  4. Bethune N. Pleural poudrage: new technique for the deliberate production of pleural adhesion as preliminary to lobectomy. J Thorac Surg. 1935;4:251–61.

    Google Scholar 

  5. Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS One. 2014;9:e87060.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rodriguez-Panadero F, Montes-Worboys A. Mechanisms of pleurodesis. Respiration. 2012;83:91–8.

    Article  PubMed  Google Scholar 

  7. Kamiyoshihara M, Ibe T, Kakegawa S, Sato K, Takise A, Takeyoshi I. Late-onset chylothorax after blunt chest trauma at an interval of 20 years: report of a case. Surg Today. 2008;38:56–8.

    Article  PubMed  Google Scholar 

  8. Okamoto H, Shoin S, Koshimura S, Shimizu R. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol. 1967;11:323–6.

    Article  CAS  PubMed  Google Scholar 

  9. Muta F, Takamori S, Matsuo T, Iwasaki Y, Yoshiyama K, Shirouzu K. Changes in the pleural cavity by pleurodesis using talc or201 OK-432: an experimental study. Surg Today. 2011;41:111–4.

    Article  PubMed  Google Scholar 

  10. Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet. 1997;349:251–2.

    Article  CAS  PubMed  Google Scholar 

  11. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg. 1999;177:437–40.

    Article  CAS  PubMed  Google Scholar 

  12. Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res. 2000;6:957–65.

    CAS  PubMed  Google Scholar 

  13. Yano S, Nokihara H, Haraguchi M, Prajuli P, Shinohara T, Kawano T, et al. Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice. Oncl Res. 1997;9:573–9.

    CAS  Google Scholar 

  14. Hurewitz AN, Lidonicci K, Wu CL, Reim D, Zucker S. Histologic changes of doxycycline pleurodesis in rabbits. Effect of concentration and pH. Chest. 1994;106:1241–5.

    Article  CAS  PubMed  Google Scholar 

  15. Mitchem RE, Herndon BL, Fiorella RM, Molteni A, Battie CN, Reisz GR. Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model. Ann Thorac Surg. 1999;67:917–21.

    Article  CAS  PubMed  Google Scholar 

  16. Saban MR, Mémet S, Jackson DG, Ash J, Roig AA, Israël A, et al. Visualization of lymphatic vessels through NF-kappaB activity. Blood. 2004;104:3228–30.

    Article  CAS  PubMed  Google Scholar 

  17. Saban MR, Towner R, Smith N, Abbott A, Neeman M, Davis CA, et al. Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer. 2007;7:219.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120:56–64.

    Article  CAS  PubMed  Google Scholar 

  19. Kennedy L, Harley RA, Sahn SA, Strange C. Talc slurry pleurodesis. Pleural fluid and histologic analysis. Chest. 1995;107:1707–12.

    Article  CAS  PubMed  Google Scholar 

  20. Werebe EC, Pazetti R, Milanez de Campos JR, Fernandez PP, Capelozzi VL, Jatene FB, et al. Systemic distribution of talc after intrapleural administration in rats. Chest. 1999;115:190–3.

    Article  CAS  PubMed  Google Scholar 

  21. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. 2007;369:1535–9.

    Article  PubMed  Google Scholar 

  22. Ferrer J, Montes JF, Villarino MA, Light RW, García-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest. 2002;122:1018–27.

    Article  PubMed  Google Scholar 

  23. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004;170:377–82.

    Article  PubMed  Google Scholar 

  24. van den Heuvel MM, Smit HJ, Barbierato SB, Havenith CE, Beelen RH, Postmus PE. Talc-induced inflammation in the pleural cavity. Eur Respir J. 1998;12:1419–23.

    Article  PubMed  Google Scholar 

  25. Antony VB, Nasreen N, Mohammed KA, Sriram PS, Frank W, Schoenfeld N, et al. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest. 2004;126:1522–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinzo Takamori.

Ethics declarations

Conflict of interests

Iwasaki and other co-authors have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iwasaki, Y., Takamori, S., Mitsuoka, M. et al. Experimental validation of talc pleurodesis for carcinomatous pleuritis in an animal model. Gen Thorac Cardiovasc Surg 64, 409–413 (2016). https://doi.org/10.1007/s11748-016-0653-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-016-0653-0

Keywords

Navigation